Where is keymab registered in the uk? Kymab Group Ltd: The Bennet Building (B930), Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT. Registered in England. Company registration number 10414057.Why work at kymab? Led by a team with world-class antibody development experience, we recruit key people to all parts of Kymab with proven skills in genetics, genomics, clinical medicine, drug development, antibody therapeutics, disease studies, business development and financial control.Who are the investors in kymab? Our Series B financing commenced in 2014 when the Bill and Melinda Gates Foundation and the Wellcome Trust invested $40 million in Kymab and closed in 2015, when Schroder UK Public Private Trust plc (formerly Woodford Patient Capital Trust plc), the Woodford Equity Income Fund and Malin Corporation plc invested US$50 million.What is the business model of ukymab? Kymab is engaged in the discovery and development of human monoclonal antibody therapeutics. Kymab Limited discovers, develops, and commercializes human therapeutic monoclonal antibodies for the treatment of human diseases using its proprietary Kymouse platform.
Our Series B financing commenced in 2014 when the Bill and Melinda Gates Foundation and the Wellcome Trust invested $40 million in Kymab and closed in 2015, when Schroder UK Public Private Trust plc (formerly Woodford Patient Capital Trust plc), the Woodford Equity Income Fund and Malin Corporation plc invested US$50 million.